International Journal of Translational Medicine · Published 2026-05-02 · DOI 10.3390/ijtm6020020
<b>Background/Objectives</b>: Posterior cortical atrophy, also referred to as Benson’s syndrome, is a presentation of Alzheimer’s disease that occurs in 5–15% of Alzheimer’s patients. Visual processing is the predominantly affected modality in posterior cortical atrophy, and symptoms such as prosopagnosia, simultanagnosia, alexia, optic ataxia, and visual hallucinations may occur, as well as blurred vision and visual distortions. Posterior cortical atrophy is considered to be a disease without a known cause or effective treatment. <b>Methods</b>: Here, we report a patient with posterior cortical atrophy who responded to a personalized, precision medicine protocol. <b>Results</b>: The patient had improved MRI volumetrics, symptoms, and cognitive testing. She regained the ability to read, use a computer, and undertake computer-based brain training, among other cognitive improvements. She has now sustained this improvement for over one year and continues to regain her independence and confidence. <b>Conclusions</b>: These results argue for additional laboratory testing in the evaluation of patients with posterior cortical atrophy, and they support the possibility of utilizing a similar approach in a proof-of-concept trial.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →